AUTHOR INDEX
 |
|
| Browse by letter: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
|
|
|
|
|
|
|
|
|
Search results for: "J"
Results 121 - 130 of 204 shown below |
|
|
|
|
|
|
|
| Johnson, Ann |
|
| Herbert Y Meltzer, Roger Mills, Stephen Revell, Hilde Williams, Ann Johnson, Daun Bahr and Joseph H Friedman Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis doi:10.1038/npp.2009.176 Neuropsychopharmacology aop, - | Abstract | Full text | PDF | |
|
|
|
| Johnson, Bankole A |
|
| Bankole A Johnson, Nassima Ait-Daoud and Lynda T Wells Effects of Isradipine, a Dihydropyridine-Class Calcium Channel Antagonist, on D-Methamphetamine-Induced Cognitive and Physiological Changes in Humans doi:10.1016/S0893-133X(99)00116-5 Neuropsychopharmacology 22, 504-512 | Abstract | Full text | PDF | |
|
|
|
| Chamindi Seneviratne, Nassima Ait-Daoud, Jennie Z Ma, Guobo Chen, Bankole A Johnson and Ming D Li Susceptibility Locus in Neurokinin-1 Receptor Gene Associated with Alcohol Dependence doi:10.1038/npp.2009.65 Neuropsychopharmacology 34, 2442-2449 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Benjamin W |
|
| Ronald M Salomon, John S Kennedy, Benjamin W Johnson, Dennis E Schmidt, Joseph Kwentus, Harry E Gwirtsman and Michael H Ebert Association of a Critical CSF Tryptophan Threshold Level with Depressive Relapse doi:10.1038/sj.npp.1300098 Neuropsychopharmacology 28, 956-960 | Abstract | Full text | PDF | |
|
|
|
| Ronald M Salomon, John S Kennedy, Benjamin W Johnson, Jennifer Urbano Blackford, Dennis E Schmidt, Joseph Kwentus, Harry E Gwirtsman, John F Gouda and Richard G Shiavi Treatment Enhances Ultradian Rhythms of CSF Monoamine Metabolites in Patients with Major Depressive Episodes doi:10.1038/sj.npp.1300746 Neuropsychopharmacology 30, 2082-2091 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Christopher R |
|
| Harold A Sackeim, A John Rush, Mark S George, Lauren B Marangell, Mustafa M Husain, Ziad Nahas, Christopher R Johnson, Stuart Seidman, Cole Giller, Stephen Haines, Richard K Simpson and Robert R Goodman Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome doi:10.1016/S0893-133X(01)00271-8 Neuropsychopharmacology 25, 713-728 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Daniel Anthony |
|
| Daniel Anthony Johnson, Colin David Ingram, Emma Jane Grant, Mark Craighead and Sarah Elizabeth Gartside Glucocorticoid Receptor Antagonism Augments Fluoxetine-Induced Downregulation of the 5-HT Transporter doi:10.1038/npp.2008.70 Neuropsychopharmacology 34, 399-409 | Abstract | Full text | PDF | |
|
|
|
| Johnson, David E |
|
| Karen L Houseknecht, Alan S Robertson, William Zavadoski, E Michael Gibbs, David E Johnson and Hans Rollema Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects doi:10.1038/sj.npp.1301209 Neuropsychopharmacology 32, 289-297 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Douglas N |
|
| John T Little, Douglas N Johnson, Marcia Minichiello, Herb Weingartner and Trey Sunderland Combined Nicotinic and Muscarinic Blockade in Elderly Normal Volunteers: Cognitive, Behavioral, and Physiologic Responses doi:10.1016/S0893-133X(98)00002-5 Neuropsychopharmacology 19, 60-69 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Elizabeth |
|
| Gary S Wand, Lynn M Oswald, Mary E McCaul, Dean F Wong, Elizabeth Johnson, Yun Zhou, Hiroto Kuwabara and Anil Kumar Association of Amphetamine-Induced Striatal Dopamine Release and Cortisol Responses to Psychological Stress doi:10.1038/sj.npp.1301373 Neuropsychopharmacology 32, 2310-2320 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Glyn |
|
| Jody Tanabe, Thomas Crowley, Kent Hutchison, David Miller, Glyn Johnson, Yiping P Du, Gary Zerbe and Robert Freedman Ventral Striatal Blood Flow is Altered by Acute Nicotine but Not Withdrawal from Nicotine doi:10.1038/sj.npp.1301428 Neuropsychopharmacology 33, 627-633 | Abstract | Full text | PDF | |
|
|
|
| Johnson, Gordon |
|
| Gordon Johnson Lithium—Early Development, Toxicity, and Renal Function doi:10.1016/S0893-133X(98)00019-0 Neuropsychopharmacology 19, 200-205 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | |
 Previous
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
